Abstract
We had previously demonstrated that Coenzyme Q10 [(CoQ10) also commonly called ubiquinone]is present in well-measurable levels in human seminal fluid, where it probably exerts important metabolic and antioxidant functions; seminal CoQ10 concentrations show a direct correlation with seminal parameters (count and motility). Alterations of CoQ10 content were also shown in conditions associated with male infertility, such as asthenozoospermia and varicocele (VAR). The physiological role of this molecule was further clarified by inquiring into its variations in concentrations induced by different medical or surgical procedures used in male infertility treatment. We therefore evaluated CoQ10 concentration and distribution between seminal plasma and spermatozoa in VAR, before and after surgical treatment, and in infertile patients after recombinant human FSH therapy. The effect of CoQ10 on sperm motility and function had been addressed only through some in vitro experiments. In two distinct studies conducted by our group, 22 and 60 patients affected by idiopathic asthenozoospermia were enrolled, respectively. CoQ10 and its reduced form, ubiquinol, increased significantly both in seminal plasma and sperm cells after treatment, as well as spermatozoa motility. A weak linear dependence among the relative variations, at baseline and after treatment, of seminal plasma or intracellular CoQ10, ubiquinol levels and kinetic parameters was found in the treated group. Patients with lower baseline value of motility and CoQ10 levels had a statistically significant higher probability to be responders to the treatment. In conclusion, the exogenous administration of CoQ10 increases both ubiquinone and ubiquinol levels in semen and can be effective in improving sperm kinetic features in patients affected by idiopathic asthenozoospermia
Similar content being viewed by others
References
Iwasaki A, Gagnon C. Formation of reactive oxygen species in spermatozoa of infertile men. Fertil Steril 1992, 47: 409–11.
MacLeod J. The role of oxygen in the metabolism and motility of human spermatozoa. Am J Physiol 1943, 138: 512–8.
Aitken RJ, Krausz C. Oxidative stress, DNA damage and the Y chromosome. Reproduction 2001, 122: 497–506.
Agarwal A, Saleh RA. Role of oxidants in male infertility: rationale, significance and treatment. Urol Clin N Am 2002, 29: 817–27.
Jones R, Mann T, Sherins R. Peroxidative breakdown of phospholipids in human spermatozoa, spermicidal properties of fatty acid peroxides, and protective action of seminal plasma. Fertil Steril 1979, 31: 531–7.
Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation, and human sperm function. Biol Reprod 1989, 41: 183–97.
Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology 1996, 48: 835–50.
Alvarez JG, Touchstone JC, Blasco L, Storey BT. Spontaneous lipid peroxidation and production of hydrogen peroxide and superoxide in human spermatozoa: superoxide dismutase as major enzyme protectant against oxygen toxicity. J Androl 1987, 8: 338–48.
Aitken RJ. Molecular mechanisms regulating sperm function. Mol Hum Reprod 1997,3: 169–73.
Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994, 344: 721–4.
Cummins JM, Jequier AM, Kan R. Molecular biology of human male infertility: links with aging, mitochondrial genetics, and oxidative stress? Mol Reprod Dev 1994, 37: 345–62.
Geva E, Lessino JB, Lerner-Geva L, Amit A. Free radicals, antioxidants and human spermatozoa: clinical implications. Hum Reprod 1998, 13: 1422–4.
Wolf DE, Hagopian SS, Lewis RG, Voglmayr JK, Fairbanks G. Lateral regionalization and diffusion of a maturation-dependent antigen in the ram sperm plasma membrane. J Cell Biol 1996, 102: 1826–31.
Myles DG, Primakoff P. Localized surface antigens of guinea pig sperm migrate to new regions prior to fertilization. J Cell Biol 1984, 99: 1634–41.
Gaunt SJ, Brown CR, Jones R. Identification of mobile and fixed antigens on the plasma membrane of rat spermatozoa using monoclonal antibodies. Exp Cell Res 1983, 144: 275–84.
Hall JC, Hadley J, Doman T. Correlation between changes in rat sperm membrane lipids, protein, and the membrane physical state during epididymal maturation. J Androl 1991, 12: 76–87.
Lenzi A, Gandini L, Picardo M. A rationale for glutathione therapy. Hum Reprod 1998, 13: 1419–22.
Wolff H, Politch JA, Martinez A, Haimovici F, Hill JA, Anderson DJ. Leukocytospermia is associated with poor semen quality. Fertil Steril 1990, 53: 528–36.
Johnson L, Varner DD. Effect of daily spermtozoan production but not age on transit time of spermatozoa through the human epididymis. Biol Reprod 1988, 39: 812–7.
Ford WCL, Whittington K. Antioxidant treatment for male subfertility: a promise that remains unfulfilled. Hum Reprod 1998, 13: 1416–9.
Sakkas D, Mariethoz E, St. John JC. Abnormal sperm parameters in humans are indicative of an abortive apoptotic mechanism linked to the Fas-mediated pathway. Exp Cell Res 1999, 251: 350–5.
Irvine DS, Twigg J, Gordon E, Fulton N, Milne P, Aitken RJ. DNA integrity in human spermatozoa: relationship with semen quality. J Androl 2000, 21: 33–44.
Donnelly ET, O’Connell M, McClure N, Lewis SE. Differences in nuclear DNA fragmentation and mitochondrial integrity of semen and prepared human spermatozoa. Hum Reprod 2000, 15: 1552–61.
Russell LD. Editorial: The perils of sperm release — ‘let my children go’. Int J Androl 1991,14: 307–11.
Huszar G, Vigue L. Correlation between the rate of lipid peroxidation and cellular maturity as measured by creatine kinase activity in human spermatozoa. J Androl 1994, 15: 71–7.
Zalata A, Hafez T, Comhaire F. Evaluation of the role of reactive oxygen species in male infertility. Hum Reprod 1995, 10: 1444–51.
Parinaud J, Le Lannou D, Vieitez G, Griveau JF, Milhet P, Richoilley G. Enhancement of motility by treating spermatozoa with an antioxidant solution (Sperm-Fit) following ejaculation. Hum Reprod 1997, 12: 2434–6.
Babior BM, Curnutte JT, McMurrich BJ. The particulate superoxideforming system in human neutrophils. Properties of the system and further evidence supporting its participation in the respiratory burst.J Clin Invest 1976, 58: 989–96.
Aitken RJ, Buckingham D, West K, Wu FC, Zikopoulous K, Richardson DW. Differential contribution of leukocytes and spermatozoa to the generation of reactive oxygen species in the ejaculates of oligozoospermic patients and fertile donors. J Reprod Fertil 1992, 94: 451–62.
Griveau JF, Dumont E, Renard P, Callegari JP, Le Lannou D. Reactive oxygen species, lipid peroxidation and enzymatic defence systems in human spematozoa. J Reprod Fertil 1995, 103: 17–26.
Aitken RJ, West K, Buckingham D. Leukocytic infiltration into the human ejaculate and its association with semen quality, oxidative stress, and sperm function. J Androl 1994, 15: 343–52.
Aitken RJ, Buckingham DW, Brindle J, Gomez E, Baker HW, Irvine DS. Analysis of sperm movement in relation to the oxidative stress created by leukocytes in washed sperm preparation and seminal plasma. Hum Reprod 1995, 10: 2061–71.
Wolff H. The biologic significance of white blood-cells in semen. Fertil Steril 1995, 63: 1143–57.
Zini A, De Lamirande E, Gagnon C. Reactive oxygen species in semen of infertile patients: levels of superoxide dismutase- and catalase-like activities in seminal plasma and spermatozoa. Int J Androl 1993, 16: 183–8.
Smith R, Vantman D, Ponce J, Escobar J, Lissi E. Total antioxidant capacity of human seminal plasma. Hum Reprod 1996, 11: 1655–60.
Lewis SE, Boyle PM, McKinney KA, Young IS, Thompson W. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril 1995, 64: 868–70.
Sharma RK, Pasqualotto FF, Nelson DR, Thomas AJ Jr, Agarwal A. The reactive species-total antioxidant capacity score is a new measure of oxidative stress to predict male infertility. Hum Reprod 1999, 14: 2801–7.
Pasqualotto FF, Sharma RK, Kobayashi H, Nelson DR, Thomas AJ Jr, Agarwal A. Oxidative stress in normospermic men undergoing infertility evaluation. J Androl 2001, 22: 316–22.
Hendin BN, Kolettis PN, Sharma RK, Thomas AJ Jr, Agarwal A. Varicocele is associated with elevated spermatozoal reactive oxygen species production and diminished seminal plasma antioxidant capacity. J Urol 1999, 161: 1831–4.
Aksoy H, Aksoy Y, Ozbey I, Altuntas I, Akcay F. The relationship between varicocele and semen nitric oxide concentrations. Urol Res 2000, 28: 357–9.
Saleh RA, Agarwal A, Sharma RK, Nelson DR, Thomas AJ. Effect of cigarette smoking on levels of seminal oxidative stress in infertile men: a prospective study. Fertil Steril 2002, 78: 491–9.
Pasqualotto FF, Sharma RK, Potts JM, Nelson DR, Thomas AJ, Agarwal A. Seminal oxidative stress in patients with chronic prostatitis. Urology 2000, 55: 881–5.
Depuydt CE, Bosmans E, Zalata A, Schoonjans F, Comhaire F. The relation between reactive oxygen species and cytokines in andro-logical patients with or without male accessory gland infection. J Androl 1996, 17: 699–707.
Pasqualotto FF, Sharma RK, Nelson DR, Thomas AJ, Agarwal A. Relationship between oxidative stress, semen characteristics, and clinical diagnosis in men undergoing infertility investigation. Fertil Steril 2000, 73: 459–64.
Zini A, O’Bryan M, Schlegel PN. Nitric oxide synthase activity in human seminal plasma. Urology 2001, 58: 85–9.
Huang C, Li J, Zheng R, Cui K. Hydrogen peroxide-induced apoptosis in human hepatoma cells is mediated by CD95(APO-1/Fas) receptor/ligand system and may involve activation of wild-type p53. Mol Biol Rep 2000, 27: 1–11.
Sayers TJ, Brooks AD, Seki N, et al. T cell lysis of murine renal cancer: multiple signalling pathways for cell death via Fas. J Leukoc Biol 2000,68: 81–6.
Mancini A, Meucci E, Bianchi A, Milardi D, De Marinis L, Littarru G. Antioxidant systems in human seminal plasma: physiopathological meaning and new perspectives. In: Panglossi HV ed. “Antioxidants: New Research”, New York: Nova Pub. 2006, 131–47.
Dallner G, Stocker R. Coenzyme Q10. Encyclopedia of Dietary Supplements 2005, 121-31.
Groneberg DA, Kindermann B, Althammer M, et al. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 2005, 37: 1208–18.
Fawcett DW. The mammalian spermatozoon. Dev Biol 1975, 44: 394–436.
Kalen A, Appelkvist EL, Chojnacki T, Dallner G. Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis in endoplasmic reticulum-Golgi system of rat liver. J Biol Chem 1990, 265: 1158–64.
Mancini A, De Marinis L, Oradei A, Hallgass ME, Conte G, Pozza D, Littarru G. Coenzyme Q10 concentrations in normal and pathological human seminal fluid. J Androl 1994, 15: 591–4.
World Health Organization (WHO). Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge: Cambridge University Press, 1999.
Hirsh AV, Cameron KM, Tyler JP, Simpson J, Pryor JP. The Doppler assessment of varicoceles and internal spermatic vein reflux in infertile men. Br J Urol 1980, 52: 50–6.
Mancini A, Milardi D, Conte G, et al. Coenzyme Q10: another biochemical alteration linked to infertility in varicocele patients?. Metabolism 2003, 52: 402–6.
Angelitti AG, Colacicco L, Callà C, Arizzi M, Lippa S. Coenzyme Q: potentially useful index of bioenergetic and oxidative status of spermatozoa. Clin Chem 1995, 41: 217–9.
Mancini A, Conte G, De Marinis L, et al. Coenzyme Q10 levels in human seminal fluid: diagnostic and clinical implications. Mol Aspects Med 1994, 15(Suppl): s249–55.
Littarru G, Lippa S, Oradei A, Fiorini R, Mazzanti L Metabolic and diagnostic implications of human blood CoQ10 levels. In: Folkers K, Littarru GP, Yamagami T (eds). Biomedical and clinical aspects of Coenzyme Q. Amsterdam: Elsevier 1991, 167–78.
Mancini A, Conte G, Milardi D, De Marinis L, Littarru G. Relationship between sperm cell ubiquinone and seminal parameters in subjects with and without varicocele. Andrologia 1998, 30: 1–4.
Mancini A, Milardi D, Conte G, Festa R, De Marinis L, Littarru G. Seminal antioxidants in humans: preoperative and postoperative evaluation of Coenzyme Q10 in varicocele patients. Horm Metab Res 2005, 37: 428–32.
Meucci E, Milardi D, Mordente A, et al. Total antioxidant capacity in patients with varicocele. Fertil Steril 2003, 79(Suppl 3): 1577–83.
Mancini A, Milardi D, Festa R, et al. Seminal CoQ10 and male infertility: effects of medical or surgical treatment on endogenous seminal plasma concentrations. Abstracts of the 4th International Coenzyme Q10 association, Los Angeles 2005, 64-5.
Alleva R, Scaramucci A, Mantero F, Bompadre S, Leoni L, Littarru G. The protective role of ubiquinol-10 against formation of lipid hydroperoxides in human seminal fluid. Mol Aspects Med (Suppl 1) 1997, 18: 221–8.
Mohr D, Bowry VW, Stocker R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim Biophys Acta 1992, 1126: 247–54.
Balercia G, Arnaldi G, Fazioli F, et al. Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia. Andrologia 2002, 34: 107–11.
Littarru G, Tiano L. Clinical aspects of Coenzyme Q10: an update. Curr Opin Clin Nutr Metab Care 2005, 8: 641–6.
Mazzilli F, Cerasaro M, Bisanti A, Rossi T, Dondero F. Seminal parameters and the swelling test in patients with sperm before and after treatment with ubiquinone (CoQ10). 2nd International Symposium on Reproductive Medicine, Fiuggi. Rome: Acta Medica, Edizioni e Congressi 1988, 71.
Mazzilli F, Bisanti A, Rossi T, DeSantis L, Dondero F. Seminal and biological parameters in dysspermic patients with sperm hypomotility before and after treatment with ubiquinone (CoQ10). J Endocrinol Invest 1990, 13 S1, 88.
Lewin A, Lavon H. The effect of Coenzyme Q10 on sperm motility and function. Molec Aspects Med 1997, 18(Suppl): S213–9.
Balercia G, Mantero F, Armeni T, Principato G, Regoli F. Total oxyradical scavenging capacity toward different reactive species in seminal plasma and sperm cells. Clin Chem Lab Med 2003, 41: 13–9.
Balercia G, Mosca F, Mantero F, et al. Coenzyme Q(10) supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. Fertil Steril 2004, 81: 93–8.
Balercia G, Moretti S, Vignini A, et al. Role of nitric oxide concentrations on human sperm motility. J Androl 2004, 25: 245–9.
Frei B, Yamamoto Y, Niclas D, Ames BN. Evaluation of an isoluminol chemiluminescence assay for detection of hydroperoxides in human blood plasma. Annal Biochem 1998, 175: 120–30.
Langsjoen P, Langsjoen A, Willis R, Folkers K. Treatment of hypertrophic cardiomyopathy with coenzyme Q10. Mol Aspects Med 1997, 8(Suppl): S145–51.
Balercia G, Buldreghini E, Vignini A, et al. Coenzyme Q10 treatment in infertile male with idiopathic asthenozoospermia. A placebo-controlled, double blind randomized trial. Fertil Steril 2009, 91: 1785–92.
Fato R, Cavazzoni M, Castelluccio C, Parenti Castelli G, Lenaz G. Steady-state kinetics of ubiquinol-cytochrome c reductase in bovine heart submitochondrial particles: diffusional effects. Biochem J 1993, 290: 225–36.
Kelso KA, Redpath A, Noble RC, Speake BK. Lipid and antioxidant changes in spermatozoa and seminal plasma throughout the reproductive period of bulls. J Reprod Fertil 1997, 109: 1–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Balercia, G., Mancini, A., Paggi, F. et al. Coenzyme Q10 and male infertility. J Endocrinol Invest 32, 626–632 (2009). https://doi.org/10.1007/BF03346521
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346521